...
机译:神经性疼痛抑制剂RAP-103是一种有效的微胶囊CCL1 / CCR8抑制剂
Kyushu Univ Grad Sch Pharmaceut Sci Lab Pathophysiol Higashi Ku 3-1-1 Maidashi Fukuoka;
Kyushu Univ Grad Sch Pharmaceut Sci Lab Pathophysiol Higashi Ku 3-1-1 Maidashi Fukuoka;
Kyushu Univ Grad Sch Pharmaceut Sci Lab Pathophysiol Higashi Ku 3-1-1 Maidashi Fukuoka;
Kyushu Univ Grad Sch Pharmaceut Sci Lab Pathophysiol Higashi Ku 3-1-1 Maidashi Fukuoka;
Kyushu Univ Grad Sch Pharmaceut Sci Lab Pathophysiol Higashi Ku 3-1-1 Maidashi Fukuoka;
Univ Laval Dept Pediat Ctr Rech Inst Univ Cardiol &
Pneumol Quebec 2725 Chemin Ste Foy Quebec;
Univ Laval Dept Pediat Ctr Rech Inst Univ Cardiol &
Pneumol Quebec 2725 Chemin Ste Foy Quebec;
Creat Biopeptides Rockville MD 20854 USA;
Creat Biopeptides Rockville MD 20854 USA;
Chronic pain; DAPTA; CCR5; Microglia; Chemotaxis;
机译:神经性疼痛抑制剂RAP-103是一种有效的微胶囊CCL1 / CCR8抑制剂
机译:Dexmedetomidine通过MIR-618 / P2Y12途径的调节抑制微胶质激活来减轻糖尿病神经病疼痛
机译:通过调节Th2浸润并抑制捕获神经损伤的大鼠脊髓中的微胶质激活来减轻神经病疼痛
机译:基于假素抑制剂设计方法的P60〜(C-SRC)PTK有效肽抑制剂的开发与表征
机译:吡格列酮作用于脊髓PPARgamma以抑制神经性疼痛的发生和维持。
机译:小胶质细胞抑制剂在神经性疼痛和吗啡耐受中的调节机制和治疗潜力
机译:IKBKB siRNA封装的聚(乳酸 - 共乙醇酸)纳米颗粒通过抑制微胶质激活来减少神经性疼痛